ECHOLIGHT S.P.A.

Echolight S.p.A. is an Italian medical device manufacturer specializing in bone density assessment and osteoporosis diagnosis. The company originated as a spin-off from Italy's Consiglio Nazionale delle Ricerche (CNR) and markets the EchoS system—a non-ionizing radiation bone densitometer that uses proprietary Radiofrequency Echographic Multi Spectrometry (R.E.M.S.) technology. The EchoS device performs ultrasound-based scanning of the lumbar spine and proximal femur to evaluate bone mineral density (BMD), T-score, Z-score, and bone microarchitecture quality without exposing patients to ionizing radiation. Scan time is rapid: 80 seconds for spine assessment, 40 seconds for femur. The system produces immediate medical reports with fracture risk indices and body composition data. Key clinical advantages over dual-energy X-ray absorptiometry (DXA) and quantitative ultrasound (QUS) include radiation-free operation, portability, lack of need for certified operators or shielded rooms, and applicability to pediatric, pregnant, diabetic, oncology, and secondary osteoporosis patients. EchoS is available in both stationary and portable configurations. The company holds FDA clearance, CE marking, ISO 13485:2016 quality management certification, ISO 9001:2015 compliance, and multiple international regulatory approvals. Echolight's R.E.M.S. technology is recognized in Italian Ministry of Health clinical guidelines (ISS guidelines on fragility fracture diagnosis and risk stratification). The company engages in ongoing clinical validation at major international osteoporosis centers and participates in scientific symposia including WCO-IOF-ESCEO conferences.